BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance is a research paper published in Cancer Discovery (2023). On theSindex it has a DataRank of 1.6. It has been cited 73 times, with 55 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.646
From this paper's citation signal
Citation Network Contribution
0.978
From 39 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 55 citers.
NCI NIH HHS
Grant: U54 CA274291
European Research Council
Grant: 101052444
Fondation pour la Recherche Médicale
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
NIH/NCI
European Research Council
Deutsche Forschungsgemeinschaft
Institut National Du Cancer
Stand Up To Cancer
US DoD BCRP
Association pour la recherche sur la cancer
Mark Foundation For Cancer Research
Elitenetzwerk Bayern
Agence Nationale de la Recherche
Ligue Contre le Cancer
Institut Universitaire de France
Labex Immuno-Oncology
FWCI
6.61
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals